(1) Chen, W.; Zheng, R.; Baade, P. D.; Zhang, S.; Zeng, H.; Bray, F.; Jemal, A.; Yu, X. Q.; He, J. Cancer Statistics in China, 2015. CA Cancer J Clin 2016, 66 (2), 115–132. https://doi.org/10.3322/caac.21338.
(2) Gao, S.; Li, N.; Wang, S.; Zhang, F.; Wei, W.; Li, N.; Bi, N.; Wang, Z.; He, J. Lung Cancer in People’s Republic of China. Journal of Thoracic Oncology 2020, 15 (10), 1567–1576. https://doi.org/10.1016/j.jtho.2020.04.028.
(3) Mayne, N. R.; Lin, B. K.; Darling, A. J.; Raman, V.; Patel, D. C.; Liou, D. Z.; D’Amico, T. A.; Yang, C.-F. J. Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-Stage Non-Small-Cell Lung Cancer. Ann Surg 2020, 272 (6), 925–929. https://doi.org/10.1097/SLA.0000000000004363.
(4) A, G.-C.; A, K.; K, S.; L, G.-K. A Single-Institution Retrospective Analysis of the Differences between 7th and 8th Edition of the UICC TNM Staging System in Patients with Advanced Lung Cancer. European review for medical and pharmacological sciences 2020, 24 (16). https://doi.org/10.26355/eurrev_202008_22636.
(5) D’Andrea, E.; Choudhry, N. K.; Raby, B.; Weinhouse, G. L.; Najafzadeh, M. A Bronchial-Airway Gene-Expression Classifier to Improve the Diagnosis of Lung Cancer: Clinical Outcomes and Cost-Effectiveness Analysis. Int J Cancer 2020, 146 (3), 781–790. https://doi.org/10.1002/ijc.32333.
(6) M, M.; Y, H.; M, I.; S, K.; Y, I.; R, S.; T, U.; T, H.; F, M.; K, N.; K, I.; M, S. Neutrophil-to-Lymphocyte Ratio and Histological Type Might Predict Clinical Responses to Eriburin-Based Treatment in Patients with Metastatic Breast Cancer. Breast cancer (Tokyo, Japan) 2020, 27 (4). https://doi.org/10.1007/s12282-020-01069-0.
(7) Tiainen, S.; Rilla, K.; Hämäläinen, K.; Oikari, S.; Auvinen, P. The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio and the Monocyte-to-Lymphocyte Ratio in Early Breast Cancer, Especially in the HER2+ Subtype. Breast Cancer Res Treat 2021, 185 (1), 63–72. https://doi.org/10.1007/s10549-020-05925-7.
(8) Shiina, Y.; Nakajima, T.; Yamamoto, T.; Tanaka, K.; Sakairi, Y.; Wada, H.; Suzuki, H.; Yoshino, I. The D-Dimer Level Predicts the Postoperative Prognosis in Patients with Non-Small Cell Lung Cancer. PLoS One 2019, 14 (12), e0222050. https://doi.org/10.1371/journal.pone.0222050.
(9) Ma, J.; Kuzman, J.; Ray, A.; Lawson, B. O.; Khong, B.; Xuan, S.; Hahn, A. W.; Khong, H. T. Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictor for Recurrence in Patients with Stage III Melanoma. Sci Rep 2018, 8 (1), 4044. https://doi.org/10.1038/s41598-018-22425-3.
(10) Pine, J. K.; Morris, E.; Hutchins, G. G.; West, N. P.; Jayne, D. G.; Quirke, P.; Prasad, K. R. Systemic Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer: The Relationship to Patient Survival, Tumour Biology and Local Lymphocytic Response to Tumour. Br J Cancer 2015, 113 (2), 204–211. https://doi.org/10.1038/bjc.2015.87.
(11) Feng, J.-F.; Huang, Y.; Chen, Q.-X. Preoperative Platelet Lymphocyte Ratio (PLR) Is Superior to Neutrophil Lymphocyte Ratio (NLR) as a Predictive Factor in Patients with Esophageal Squamous Cell Carcinoma. World J Surg Oncol 2014, 12, 58. https://doi.org/10.1186/1477-7819-12-58.
(12) Topkan, E.; Mertsoylu, H.; Kucuk, A.; Besen, A. A.; Sezer, A.; Sezen, D.; Bolukbasi, Y.; Selek, U.; Pehlivan, B. Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy. Gastroenterol Res Pract 2020, 2020, 5701949. https://doi.org/10.1155/2020/5701949.
(13) Tanizaki, J.; Haratani, K.; Hayashi, H.; Chiba, Y.; Nakamura, Y.; Yonesaka, K.; Kudo, K.; Kaneda, H.; Hasegawa, Y.; Tanaka, K.; Takeda, M.; Ito, A.; Nakagawa, K. Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab. Journal of Thoracic Oncology 2018, 13 (1), 97–105. https://doi.org/10.1016/j.jtho.2017.10.030.
(14) Galvano, A.; Peri, M.; Guarini, A. A.; Castiglia, M.; Grassadonia, A.; De Tursi, M.; Irtelli, L.; Rizzo, S.; Bertani, A.; Gristina, V.; Barraco, N.; Russo, A.; Natoli, C.; Bazan, V. Analysis of Systemic Inflammatory Biomarkers in Neuroendocrine Carcinomas of the Lung: Prognostic and Predictive Significance of NLR, LDH, ALI, and LIPI Score. Ther Adv Med Oncol 2020, 12, 1758835920942378. https://doi.org/10.1177/1758835920942378.
(15) Balkwill, F.; Mantovani, A. Inflammation and Cancer: Back to Virchow? Lancet 2001, 357 (9255), 539–545. https://doi.org/10.1016/S0140-6736(00)04046-0.
(16) Diakos, C. I.; Charles, K. A.; McMillan, D. C.; Clarke, S. J. Cancer-Related Inflammation and Treatment Effectiveness. Lancet Oncol 2014, 15 (11), e493-503. https://doi.org/10.1016/S1470-2045(14)70263-3.
(17) Elinav, E.; Nowarski, R.; Thaiss, C. A.; Hu, B.; Jin, C.; Flavell, R. A. Inflammation-Induced Cancer: Crosstalk between Tumours, Immune Cells and Microorganisms. Nat Rev Cancer 2013, 13 (11), 759–771. https://doi.org/10.1038/nrc3611.
(18) Greten, F. R.; Grivennikov, S. I. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 2019, 51 (1), 27–41. https://doi.org/10.1016/j.immuni.2019.06.025.
(19) Ray-Coquard, I.; Cropet, C.; Van Glabbeke, M.; Sebban, C.; Le Cesne, A.; Judson, I.; Tredan, O.; Verweij, J.; Biron, P.; Labidi, I.; Guastalla, J.-P.; Bachelot, T.; Perol, D.; Chabaud, S.; Hogendoorn, P. C. W.; Cassier, P.; Dufresne, A.; Blay, J.-Y.; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas. Cancer Res 2009, 69 (13), 5383–5391. https://doi.org/10.1158/0008-5472.CAN-08-3845.
(20) Farhood, B.; Najafi, M.; Mortezaee, K. CD8+ Cytotoxic T Lymphocytes in Cancer Immunotherapy: A Review. J Cell Physiol 2019, 234 (6), 8509–8521. https://doi.org/10.1002/jcp.27782.
(21) Ardi, V. C.; Kupriyanova, T. A.; Deryugina, E. I.; Quigley, J. P. Human Neutrophils Uniquely Release TIMP-Free MMP-9 to Provide a Potent Catalytic Stimulator of Angiogenesis. Proc Natl Acad Sci U S A 2007, 104 (51), 20262–20267. https://doi.org/10.1073/pnas.0706438104.
(22) Coffelt, S. B.; Wellenstein, M. D.; de Visser, K. E. Neutrophils in Cancer: Neutral No More. Nat Rev Cancer 2016, 16 (7), 431–446. https://doi.org/10.1038/nrc.2016.52.
(23) Chittezhath, M.; Dhillon, M. K.; Lim, J. Y.; Laoui, D.; Shalova, I. N.; Teo, Y. L.; Chen, J.; Kamaraj, R.; Raman, L.; Lum, J.; Thamboo, T. P.; Chiong, E.; Zolezzi, F.; Yang, H.; Van Ginderachter, J. A.; Poidinger, M.; Wong, A. S. C.; Biswas, S. K. Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression. Immunity 2014, 41 (5), 815–829. https://doi.org/10.1016/j.immuni.2014.09.014.
(24) Schlesinger, M. Role of Platelets and Platelet Receptors in Cancer Metastasis. J Hematol Oncol 2018, 11 (1), 125. https://doi.org/10.1186/s13045-018-0669-2.
(25) Lu, Y.; Zhang, L.; Zhang, Q.; Zhang, Y.; Chen, D.; Lou, J.; Jiang, J.; Ren, C. The Association of D-Dimer with Clinicopathological Features of Breast Cancer and Its Usefulness in Differential Diagnosis: A Systematic Review and Meta-Analysis. PLoS One2019, 14 (9), e0221374. https://doi.org/10.1371/journal.pone.0221374.